4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]benzamide
Chemical Structure Depiction of
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]benzamide
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]benzamide
Compound characteristics
Compound ID: | L610-0145 |
Compound Name: | 4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]benzamide |
Molecular Weight: | 489.62 |
Molecular Formula: | C28 H35 N5 O3 |
Smiles: | CCN1CCN(CCNC(c2ccc(CN3C(C4CCCN4C(c4ccccc34)=O)=O)cc2)=O)CC1 |
Stereo: | RACEMIC MIXTURE |
logP: | 0.9681 |
logD: | 0.1755 |
logSw: | -2.5337 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 64.047 |
InChI Key: | GEYVAKGMDZHNPO-VWLOTQADSA-N |